We are live on
!
Find out more
DC
Diametric Capital Portfolio holdings
AUM
$385M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
-1.96%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
–
AUM
$385M
AUM Growth
+$11.7M
(+3.1%)
Cap. Flow
+$39.6M
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
618
New
251
Increased
83
Reduced
136
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$12.1M |
| 2 |
FPS
Forgent Power Solutions
FPS
|
+$4.81M |
| 3 |
PENN Entertainment
PENN
|
+$4.5M |
| 4 |
Flutter Entertainment
FLUT
|
+$3.99M |
| 5 |
A2Z Smart Technologies
AZ
|
+$3.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harrow
HROW
|
+$7.36M |
| 2 |
Red Rock Resorts
RRR
|
+$5.36M |
| 3 |
AIFC
AI Financial Corp
AIFC
|
+$5.22M |
| 4 |
Warner Bros
WBD
|
+$3.2M |
| 5 |
MGM Resorts International
MGM
|
+$2.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.21% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Technology | 14.08% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Nautilus Biotechnolgy
NAUT
$216M
| $88.5K | 0.02% |
+22,806
| New | +$56K |
|
|
SGMO
427
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $87.3K | 0.02% |
353,477
-41,855
| -11% | -$16.7K |
|
428
ProKidney
PROK
$314M
| $85.6K | 0.02% |
+47,827
| New | +$101K |
|
429
SmartRent
SMRT
$187M
| $83.8K | 0.02% |
+55,858
| New | +$94.4K |
|
|
XMAX
430
XMAX Inc
XMAX
$547M
| $83.5K | 0.02% |
+11,529
| New | +$71.6K |
|
431
Orchestra BioMed
OBIO
$217M
| $80.4K | 0.02% |
+18,919
| New | +$80.5K |
|
|
BCHT
432
Birchtech Corp
BCHT
$39.7M
| $77.8K | 0.02% |
+41,685
| New | +$91K |
|
433
Fossil Group
FOSL
$246M
| $77.4K | 0.02% |
+17,968
| New | +$72.5K |
|
|
CLYM
434
Climb Bio
CLYM
$720M
| $76.8K | 0.02% |
+11,218
| New | +$64.7K |
|
435
SES AI
SES
$218M
| $68.3K | 0.02% |
+70,989
| New | +$121K |
|
|
VENU
436
Venu Holding Corp
VENU
$141M
| $67.8K | 0.02% |
20,489
-16,363
| -44% | -$94.4K |
|
437
Neumora Therapeutics
NMRA
$285M
| $63.9K | 0.02% |
+32,762
| New | +$84.9K |
|
438
CAMP4 Therapeutics
CAMP
$161M
| $63.7K | 0.02% |
+14,446
| New | +$68.6K |
|
439
Lantronix
LTRX
$246M
| $62.9K | 0.02% |
+12,009
| New | +$73.4K |
|
440
SAB Biotherapeutics
SABS
$274M
| $62.4K | 0.02% |
+16,292
| New | +$65K |
|
441
Veritone
VERI
$105M
| $62.4K | 0.02% |
+31,667
| New | +$107K |
|
442
Caribou Biosciences
CRBU
$165M
| $62.3K | 0.02% |
+32,793
| New | +$56.3K |
|
|
FWDI
443
Forward Industries Inc
FWDI
$319M
| $61.9K | 0.02% |
+13,979
| New | +$79.9K |
|
|
EMPD
444
Empery Digital
EMPD
$95.9M
| $59.7K | 0.02% |
+14,117
| New | +$61.1K |
|
445
Microbot Medical
MBOT
$119M
| $58.8K | 0.02% |
+24,382
| New | +$54.5K |
|
|
ORBS
446
Eightco Holdings
ORBS
$249M
| $57.1K | 0.01% |
+61,261
| New | +$78.4K |
|
447
GSI Technology
GSIT
$238M
| $56.5K | 0.01% |
+10,996
| New | +$79.8K |
|
448
Comstock
LODE
$300M
| $56.4K | 0.01% |
18,505
-613,020
| -97% | -$2.01M |
|
449
Virgin Galactic
SPCE
$343M
| $55.5K | 0.01% |
+22,859
| New | +$62K |
|
450
1stdibs.com
DIBS
$162M
| $55.2K | 0.01% |
+10,033
| New | +$55.6K |
|
Similar funds
GCP
GA
BAMG
VI
T
GAG
SCP
BHWM
Diametric Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Diametric Capital held 618 positions worth $385M, up 3.1% from $373M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Diametric Capital deployed $39.6M of net new capital in Q1 2026, opening 251 new positions and adding to 83 existing holdings. Its largest new stake was Forgent Power Solutions: 144,593 shares worth $4.23M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Harrow, an estimated $7.36M trimmed.
- Diametric Capital's largest Q1 2026 buy was Forgent Power Solutions: 144,593 shares worth $4.23M.
- Diametric Capital added most to Precigen in Q1 2026, an estimated $12.1M increase.
- Diametric Capital's biggest Q1 2026 reduction was Harrow, cutting an estimated $7.36M.
- Diametric Capital fully exited Red Rock Resorts in Q1 2026, selling an estimated $5.36M.
- Diametric Capital's ten largest holdings make up 20% of its $385M portfolio in Q1 2026.
- Diametric Capital opened 251 new positions and closed 145 in Q1 2026.
- Diametric Capital's portfolio value rose 3.1% quarter-over-quarter to $385M.
Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.